Zobrazeno 1 - 10
of 98
pro vyhledávání: '"Carmen, Gherasim"'
Autor:
Qian Wang, Ian A. Mellis, Yicheng Guo, Carmen Gherasim, Riccardo Valdez, Aubree Gordon, David D. Ho, Lihong Liu
Publikováno v:
Cell Reports Medicine, Vol 5, Iss 9, Pp 101701- (2024)
Summary: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-neutralizing antibodies are substantially expanded 1 month after a shot of XBB.1.5 monovalent mRNA vaccine (XBB.1.5 MV) booster, but the durability of this response remains unknown
Externí odkaz:
https://doaj.org/article/f5b9cb0a4d4e4260850a9ce6c4be20f5
Autor:
Carmen Gherasim, Mihai Asandulesa, Nicusor Fifere, Florica Doroftei, Daniel Tîmpu, Anton Airinei
Publikováno v:
Nanomaterials, Vol 14, Iss 9, p 759 (2024)
Polymer nanocomposite films based on poly(vinyl pyrrolidone) incorporated with different amounts of copper oxide (CuO) nanoparticles were prepared by the solution casting technique. The PVP/CuO nanocomposites were analyzed by X-ray diffractometry (XR
Externí odkaz:
https://doaj.org/article/ae642689dfb741579a2511cf9e4c7f86
Autor:
Kelly M. O’Shea, Charles F. Schuler, Jesse Chen, Jonathan P. Troost, Pamela T. Wong, Kelsea Chen, Daniel R. O’Shea, Westley Peng, Carmen Gherasim, David M. Manthei, Riccardo Valdez, James L. Baldwin, James R. Baker
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
ImportanceThe degree of immune protection against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) variants provided by infection versus vaccination with wild-type virus remains unresolved, which could influence future vaccine strategies.
Externí odkaz:
https://doaj.org/article/3cd9b377ce6b40d6b045e0b6603f2ae6
Autor:
Charles F. Schuler, Carmen Gherasim, Kelly O’Shea, David M. Manthei, Jesse Chen, Cristyn Zettel, Jonathan P. Troost, Andrew A. Kennedy, Andrew W. Tai, Donald A. Giacherio, Riccardo Valdez, James L. Baldwin, James R. Baker
Publikováno v:
Microbiology Spectrum, Vol 9, Iss 2 (2021)
ABSTRACT Uncertainty exists whether mild COVID-19 confers immunity to reinfection. Questions also remain regarding the persistence of antibodies against SARS-CoV-2 after mild infection. We prospectively followed at-risk individuals with and without S
Externí odkaz:
https://doaj.org/article/fb316cf422194c3691819a59fbab0254
Autor:
Charles F Schuler, Carmen Gherasim, Kelly O'Shea, David M Manthei, Jesse Chen, Don Giacherio, Jonathan P Troost, James L Baldwin, James R Baker
Publikováno v:
PLoS ONE, Vol 16, Iss 3, p e0248729 (2021)
BackgroundAs COVID-19 vaccines become available, screening individuals for prior COVID-19 infection and vaccine response in point-of-care (POC) settings has renewed interest. We prospectively screened at-risk individuals for SARS-CoV-2 spike and nucl
Externí odkaz:
https://doaj.org/article/96e8a5c980564ecf91b92c95ba97a12b
Autor:
Qian Wang, Anthony Bowen, Riccardo Valdez, Carmen Gherasim, Aubree Gordon, Lihong Liu, David D. Ho
Publikováno v:
New England Journal of Medicine. 388:567-569
Autor:
Carmen Gherasim, Petronela Pascariu, Mihai Asandulesa, Marius Dobromir, Florica Doroftei, Nicusor Fifere, Andrei Dascalu, Anton Airinei
Publikováno v:
Ceramics International. 48:25556-25568
Autor:
JoAnna Williams, Kriselle Maris Lao, Elizabeth Sykes, Carmen Gherasim, Xander M R van Wijk, Jieli Li, Qian Sun
Publikováno v:
Pediatric Nephrology. 37:677-681
Serum creatinine concentration is a primary component of Bedside Schwartz equation for estimated glomerular filtration rate (eGFR) in children. To standardize creatinine measurement, most manufacturers have adopted calibration procedures traceable to
Autor:
Qian Wang, Anthony Bowen, Riccardo Valdez, Carmen Gherasim, Aubree Gordon, Lihong Liu, David D. Ho
The SARS-CoV-2 Omicron variant and its numerous sub-lineages have exhibited a striking ability to evade humoral immune responses induced by prior vaccination or infection. The Food and Drug Administration (FDA) has recently granted Emergency Use Auth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::741122af8e3d73080c0916e3af790800
https://doi.org/10.1101/2022.10.22.513349
https://doi.org/10.1101/2022.10.22.513349
Autor:
Lee F. Schroeder, David M Manthei, Anthony M Sinay, Donald A. Giacherio, Riccardo Valdez, Jason F Whalen, Shih-Hon Li, Carmen Gherasim
Publikováno v:
American Journal of Clinical Pathology
Objectives Serologic testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has experienced a changing landscape of available assays coupled with uncertainty surrounding performance characteristics. Studies are needed to directly co